Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Enters transfer of business deal and a premix and market-ready solutions supply deal for its product Fruitflow. Both will take effect from January 1, 2023. Says the agreements should lead to a substantial increase annual sales and net profit.

Expects to report revenue of £426,000 for the year ended March 31 and an underlying operating loss of £173,000. Revenue for financial 2021 amounted to £211,195.

Files new patent application related to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans.

Fruitflow is a supplement that supports healthy blood flow and heart health, Provexis explains.

Current stock price: 0.98 pence, up 13% on Wednesday

12-month change: down 17%

Copyright 2021 Alliance News Limited. All Rights Reserved.